LOINC Code 62973-3: PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101. It is commonly used with the system or sample type ^Patient.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Panel type: Panel
• Method: PhenX

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101
• The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a 6-item questionnaire that helps identify patients with gastroesophageal reflux disease (GERD). Patients are asked to report frequency of symptoms over the past 7 days. If the administration of the GerdQ produces a positive score for GERD, the Gastrointestinal Working Group (WG) recommends performing a pH impedence test to confirm the results and determine disease severity. Please see the Gastrointestinal WG Supplemental Information for a pH impedence test protocol. The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a proprietary instrument that is available for use with permission from AstraZeneca. To obtain permission, contact AstraZeneca at PROinformation@astrazeneca.com and complete a License Agreement.
• Dis; Diseases; Dz; GE; GERD; GERD symptoms proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Sx

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions